nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—CHRM3—nephrolithiasis	0.849	1	CbGaD
Hyoscyamine—Oral lesion—Hydrochlorothiazide—nephrolithiasis	0.0112	0.129	CcSEcCtD
Hyoscyamine—CHRM4—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00873	0.179	CbGpPWpGaD
Hyoscyamine—CHRM3—ureter—nephrolithiasis	0.00781	0.865	CbGeAlD
Hyoscyamine—Oral disorder—Hydrochlorothiazide—nephrolithiasis	0.0064	0.0742	CcSEcCtD
Hyoscyamine—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00589	0.121	CbGpPWpGaD
Hyoscyamine—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00581	0.119	CbGpPWpGaD
Hyoscyamine—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.00417	0.0483	CcSEcCtD
Hyoscyamine—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.00368	0.0426	CcSEcCtD
Hyoscyamine—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00235	0.0272	CcSEcCtD
Hyoscyamine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00219	0.0253	CcSEcCtD
Hyoscyamine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0245	CcSEcCtD
Hyoscyamine—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00206	0.0239	CcSEcCtD
Hyoscyamine—Stinging—Hydrochlorothiazide—nephrolithiasis	0.002	0.0231	CcSEcCtD
Hyoscyamine—CHRM4—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00193	0.0396	CbGpPWpGaD
Hyoscyamine—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00179	0.0207	CcSEcCtD
Hyoscyamine—CHRM4—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00162	0.0333	CbGpPWpGaD
Hyoscyamine—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0187	CcSEcCtD
Hyoscyamine—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00153	0.0177	CcSEcCtD
Hyoscyamine—Methylscopolamine bromide—CHRM3—nephrolithiasis	0.0015	0.209	CrCbGaD
Hyoscyamine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00144	0.0167	CcSEcCtD
Hyoscyamine—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0154	CcSEcCtD
Hyoscyamine—Cyclopentolate—CHRM3—nephrolithiasis	0.00132	0.183	CrCbGaD
Hyoscyamine—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0013	0.0267	CbGpPWpGaD
Hyoscyamine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00129	0.0149	CcSEcCtD
Hyoscyamine—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00128	0.0264	CbGpPWpGaD
Hyoscyamine—Scopolamine—CHRM3—nephrolithiasis	0.00128	0.178	CrCbGaD
Hyoscyamine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00124	0.0144	CcSEcCtD
Hyoscyamine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00123	0.0143	CcSEcCtD
Hyoscyamine—CHRM4—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00118	0.0243	CbGpPWpGaD
Hyoscyamine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00118	0.0137	CcSEcCtD
Hyoscyamine—Homatropine Methylbromide—CHRM3—nephrolithiasis	0.00111	0.154	CrCbGaD
Hyoscyamine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0128	CcSEcCtD
Hyoscyamine—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00109	0.0225	CbGpPWpGaD
Hyoscyamine—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00108	0.0222	CbGpPWpGaD
Hyoscyamine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0125	CcSEcCtD
Hyoscyamine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00107	0.0124	CcSEcCtD
Hyoscyamine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00102	0.0118	CcSEcCtD
Hyoscyamine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00102	0.0118	CcSEcCtD
Hyoscyamine—Atropine—CHRM3—nephrolithiasis	0.000998	0.139	CrCbGaD
Hyoscyamine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000989	0.0115	CcSEcCtD
Hyoscyamine—Ipratropium bromide—CHRM3—nephrolithiasis	0.000988	0.137	CrCbGaD
Hyoscyamine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000949	0.011	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000935	0.0108	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000916	0.0106	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.000892	0.0103	CcSEcCtD
Hyoscyamine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.000887	0.0103	CcSEcCtD
Hyoscyamine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00088	0.0102	CcSEcCtD
Hyoscyamine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000868	0.01	CcSEcCtD
Hyoscyamine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000827	0.00958	CcSEcCtD
Hyoscyamine—CHRM4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000822	0.0169	CbGpPWpGaD
Hyoscyamine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000798	0.0164	CbGpPWpGaD
Hyoscyamine—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000795	0.0163	CbGpPWpGaD
Hyoscyamine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000787	0.0162	CbGpPWpGaD
Hyoscyamine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000754	0.00873	CcSEcCtD
Hyoscyamine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000726	0.00841	CcSEcCtD
Hyoscyamine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000707	0.00819	CcSEcCtD
Hyoscyamine—Tension—Hydrochlorothiazide—nephrolithiasis	0.000694	0.00804	CcSEcCtD
Hyoscyamine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000693	0.00802	CcSEcCtD
Hyoscyamine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000687	0.00796	CcSEcCtD
Hyoscyamine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000667	0.00772	CcSEcCtD
Hyoscyamine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00065	0.00753	CcSEcCtD
Hyoscyamine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000646	0.00748	CcSEcCtD
Hyoscyamine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000635	0.00736	CcSEcCtD
Hyoscyamine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000634	0.00735	CcSEcCtD
Hyoscyamine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00724	CcSEcCtD
Hyoscyamine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000622	0.0072	CcSEcCtD
Hyoscyamine—CHRM3—renal system—nephrolithiasis	0.000621	0.0687	CbGeAlD
Hyoscyamine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000602	0.00697	CcSEcCtD
Hyoscyamine—CHRM3—kidney—nephrolithiasis	0.0006	0.0665	CbGeAlD
Hyoscyamine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0006	0.00695	CcSEcCtD
Hyoscyamine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000589	0.00682	CcSEcCtD
Hyoscyamine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000582	0.00674	CcSEcCtD
Hyoscyamine—CHRM4—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000578	0.0119	CbGpPWpGaD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000578	0.0119	CbGpPWpGaD
Hyoscyamine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000577	0.00668	CcSEcCtD
Hyoscyamine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000577	0.00668	CcSEcCtD
Hyoscyamine—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000571	0.0117	CbGpPWpGaD
Hyoscyamine—Shock—Hydrochlorothiazide—nephrolithiasis	0.000568	0.00658	CcSEcCtD
Hyoscyamine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000563	0.00652	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000558	0.00646	CcSEcCtD
Hyoscyamine—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000547	0.0112	CbGpPWpGaD
Hyoscyamine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000539	0.00625	CcSEcCtD
Hyoscyamine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000522	0.00605	CcSEcCtD
Hyoscyamine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000515	0.00596	CcSEcCtD
Hyoscyamine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000513	0.00594	CcSEcCtD
Hyoscyamine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000508	0.00588	CcSEcCtD
Hyoscyamine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000498	0.00576	CcSEcCtD
Hyoscyamine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000494	0.00572	CcSEcCtD
Hyoscyamine—Pain—Hydrochlorothiazide—nephrolithiasis	0.000494	0.00572	CcSEcCtD
Hyoscyamine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000476	0.00551	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000472	0.00547	CcSEcCtD
Hyoscyamine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000459	0.00531	CcSEcCtD
Hyoscyamine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000456	0.00528	CcSEcCtD
Hyoscyamine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000456	0.00528	CcSEcCtD
Hyoscyamine—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000449	0.00922	CbGpPWpGaD
Hyoscyamine—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000448	0.00919	CbGpPWpGaD
Hyoscyamine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000425	0.00492	CcSEcCtD
Hyoscyamine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000414	0.0048	CcSEcCtD
Hyoscyamine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000408	0.00473	CcSEcCtD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000402	0.00825	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000401	0.00822	CbGpPWpGaD
Hyoscyamine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000395	0.00457	CcSEcCtD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00039	0.008	CbGpPWpGaD
Hyoscyamine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00039	0.008	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000385	0.00789	CbGpPWpGaD
Hyoscyamine—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000385	0.00789	CbGpPWpGaD
Hyoscyamine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000382	0.00442	CcSEcCtD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000372	0.00764	CbGpPWpGaD
Hyoscyamine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000367	0.00425	CcSEcCtD
Hyoscyamine—Rash—Hydrochlorothiazide—nephrolithiasis	0.000364	0.00421	CcSEcCtD
Hyoscyamine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000364	0.00421	CcSEcCtD
Hyoscyamine—Headache—Hydrochlorothiazide—nephrolithiasis	0.000362	0.00419	CcSEcCtD
Hyoscyamine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000343	0.00397	CcSEcCtD
Hyoscyamine—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000325	0.00667	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000319	0.00655	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000291	0.00596	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—RGS14—nephrolithiasis	0.000281	0.00577	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.000255	0.00524	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000251	0.00515	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000248	0.00509	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000243	0.00499	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.000222	0.00456	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000215	0.00442	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000212	0.00436	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.00019	0.0039	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00019	0.00389	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000189	0.00388	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000187	0.00384	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000177	0.00364	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.000172	0.00354	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000172	0.00353	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000172	0.00352	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.00017	0.00349	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000164	0.00336	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000162	0.00332	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000151	0.0031	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.00015	0.00308	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000149	0.00307	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000148	0.00304	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000137	0.00282	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000128	0.00263	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000128	0.00262	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000126	0.00259	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	0.000126	0.00258	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000125	0.00256	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000121	0.00249	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.00012	0.00245	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000119	0.00245	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000118	0.00242	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000116	0.00239	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	0.000116	0.00238	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.000115	0.00236	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	0.000114	0.00234	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AGXT—nephrolithiasis	0.000108	0.00222	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	0.000102	0.00209	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000102	0.00209	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.000102	0.00209	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	0.000101	0.00208	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.0001	0.00206	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	9.26e-05	0.0019	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—SLC26A1—nephrolithiasis	9.19e-05	0.00189	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APRT—nephrolithiasis	9.19e-05	0.00189	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	9.14e-05	0.00188	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	8.47e-05	0.00174	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	8.44e-05	0.00173	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	8.41e-05	0.00173	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	8.36e-05	0.00172	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	8.3e-05	0.0017	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	7.69e-05	0.00158	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	7.66e-05	0.00157	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	7.59e-05	0.00156	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	7.37e-05	0.00151	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.87e-05	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	6.87e-05	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	6.85e-05	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.85e-05	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.78e-05	0.00139	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	6.78e-05	0.00139	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTH—nephrolithiasis	6.74e-05	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AQP1—nephrolithiasis	6.55e-05	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	4.97e-05	0.00102	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	4.9e-05	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	4.54e-05	0.000932	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTH—nephrolithiasis	4.53e-05	0.000929	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	4.48e-05	0.00092	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	3.38e-05	0.000694	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	2.28e-05	0.000468	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	2.27e-05	0.000467	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	2.25e-05	0.000462	CbGpPWpGaD
